LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,567,000 | -1.2% | 80,000 | 0.0% | 0.48% | +10.4% |
| Q4 2015 | $8,674,000 | -10.8% | 80,000 | -29.5% | 0.43% | -23.2% |
| Q3 2015 | $9,721,000 | -15.1% | 113,500 | 0.0% | 0.56% | -8.9% |
| Q2 2015 | $11,452,000 | +30.9% | 113,500 | 0.0% | 0.62% | -5.9% |
| Q1 2015 | $8,752,000 | +9.9% | 113,500 | -24.2% | 0.66% | -24.2% |
| Q4 2014 | $7,966,000 | +13.2% | 149,700 | 0.0% | 0.87% | -11.5% |
| Q3 2014 | $7,034,000 | -24.6% | 149,700 | 0.0% | 0.98% | -22.6% |
| Q2 2014 | $9,325,000 | -6.3% | 149,700 | +1.2% | 1.27% | -17.9% |
| Q1 2014 | $9,948,000 | +40.7% | 147,900 | +10.0% | 1.54% | -29.1% |
| Q4 2013 | $7,069,000 | – | 134,400 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |